Scotiabank Weighs in on Cameco’s FY2027 Earnings (NYSE:CCJ)

Cameco Corporation (NYSE:CCJ) (TSE:CCO) – Equities researchers at Scotiabank lowered their FY2027 earnings estimates for shares of Cameco in a report issued on Friday, April 17th. Scotiabank analyst O. Wowkodaw now anticipates that the basic materials company will post earnings of $1.47 per share for the year, down from their previous forecast of $1.48. The consensus estimate for Cameco’s current full-year earnings is $1.57 per share.

Other analysts have also recently issued reports about the stock. The Goldman Sachs Group restated a “buy” rating and set a $131.00 target price on shares of Cameco in a research report on Wednesday, February 4th. Zacks Research cut shares of Cameco from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, February 18th. Canadian Imperial Bank of Commerce upped their target price on shares of Cameco to $202.00 in a research report on Monday, March 9th. Weiss Ratings upgraded shares of Cameco from a “hold (c)” rating to a “buy (b-)” rating in a research report on Monday, February 23rd. Finally, William Blair initiated coverage on shares of Cameco in a research report on Monday. They set an “outperform” rating on the stock. Twelve research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $150.40.

Cameco Stock Up 2.4%

Shares of CCJ stock opened at $123.58 on Tuesday. The company’s fifty day simple moving average is $114.20 and its two-hundred day simple moving average is $103.51. The company has a quick ratio of 1.68, a current ratio of 2.47 and a debt-to-equity ratio of 0.14. The stock has a market cap of $53.82 billion, a P/E ratio of 127.40 and a beta of 1.02. Cameco has a 52 week low of $38.97 and a 52 week high of $135.24.

Cameco (NYSE:CCJ) (TSE:CCO) last announced its quarterly earnings results on Friday, February 13th. The basic materials company reported $0.36 EPS for the quarter, topping the consensus estimate of $0.29 by $0.07. The business had revenue of $874.57 million for the quarter, compared to analysts’ expectations of $782.13 million. Cameco had a net margin of 17.00% and a return on equity of 9.35%. The business’s quarterly revenue was up 1.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.36 EPS.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in CCJ. Financial Consulate Inc. bought a new position in shares of Cameco during the third quarter valued at approximately $25,000. Nisa Investment Advisors LLC bought a new stake in Cameco during the 4th quarter valued at $25,000. Founders Capital Management bought a new stake in Cameco during the 4th quarter valued at $27,000. Strategic Advocates LLC bought a new stake in Cameco during the 3rd quarter valued at $28,000. Finally, Mcguire Capital Advisors Inc. bought a new stake in Cameco during the 4th quarter valued at $28,000. 70.21% of the stock is currently owned by institutional investors.

About Cameco

Cameco Corporation (NYSE: CCJ) is a leading producer of uranium and a supplier to the global nuclear power industry. Headquartered in Saskatoon, Saskatchewan, Canada, the company is engaged in the exploration, mining, milling and sale of uranium concentrate, commonly known as yellowcake, which is used as fuel for nuclear reactors. Cameco also participates in services and activities that support the front end of the nuclear fuel cycle, including processing and marketing of uranium to utilities under long‑term and spot contracts.

The company’s operations have historically centered in Canada and the United States, where it operates and develops uranium mining and processing properties.